Advanced search×

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting.

Colleen Gorman CG Koch, Liang L Li, Andra I AI Duncan, Tomislav T Mihaljevic, Delos M DM Cosgrove, Floyd D FD Loop, Norman J NJ Starr, and Eugene H EH Blackstone

Crit Care Med 34(6):1608-16 (2006) PMID 16607235

Our objective was to quantify incremental risk associated with transfusion of packed red blood cells and other blood components on morbidity after coronary artery bypass grafting.

Referenced by 1 articles

DOI: 10.1097/01.CCM.0000217920.48559.D8
Version: za2963e q8za9 q8zb2 q8zcc q8zd2 q8zee q8zf6 q8zg5

Similar articles you may find interesting…

  1. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.
    Bruce D BD Spiess, David D Royston, ... Andrea A Nadel

    Transfusion 44(8):1143-8 (2004) PMID 15265117

    PLT transfusion in the perioperative period of CABG was associated with increased risk for serious adverse events. PLT transfusion may be a surrogate marker for sicker patients and have no causal role in the outcomes observed. However, a direct contribution to outcomes remains possible....
  2. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity.
    Alexander B AB Kenton, Suzanne S Hegemier, ... Caraciolo J CJ Fernandes

    J Perinatol 25(3):173-7 (2005) PMID 15578029

    A total of 46 infants met the study criteria (gestational age 28+/-4 weeks and birth weight 1166+/-756 g, mean+/-SD). There were a total of 406 platelet transfusions administered to the study population. Of these, 151 (37.2%) were given in the presence of active bleeding, with 62% of these resulting...